- Home
- INKT vs CLDI Comparison
INKT vs CLDI Comparison
Compare INKT & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- CLDI
- Stock Information
- Founded
- INKT 2017
- CLDI 2014
- Country
- INKT United States
- CLDI United States
- Employees
- INKT N/A
- CLDI N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INKT Health Care
- CLDI Health Care
- Exchange
- INKT Nasdaq
- CLDI Nasdaq
- Market Cap
- INKT 36.7M
- CLDI 35.2M
- IPO Year
- INKT 2021
- CLDI N/A
- Fundamental
- Price
- INKT $10.10
- CLDI $1.05
- Analyst Decision
- INKT Strong Buy
- CLDI Strong Buy
- Analyst Count
- INKT 2
- CLDI 3
- Target Price
- INKT $6.50
- CLDI $16.67
- AVG Volume (30 Days)
- INKT 70.0K
- CLDI 2.7M
- Earning Date
- INKT 03-20-2025
- CLDI 03-14-2025
- Dividend Yield
- INKT N/A
- CLDI N/A
- EPS Growth
- INKT N/A
- CLDI N/A
- EPS
- INKT N/A
- CLDI N/A
- Revenue
- INKT N/A
- CLDI N/A
- Revenue This Year
- INKT N/A
- CLDI N/A
- Revenue Next Year
- INKT N/A
- CLDI N/A
- P/E Ratio
- INKT N/A
- CLDI N/A
- Revenue Growth
- INKT N/A
- CLDI N/A
- 52 Week Low
- INKT $4.56
- CLDI $0.58
- 52 Week High
- INKT $19.00
- CLDI $16.80
- Technical
- Relative Strength Index (RSI)
- INKT 54.73
- CLDI 45.04
- Support Level
- INKT $8.97
- CLDI $1.16
- Resistance Level
- INKT $9.98
- CLDI $1.30
- Average True Range (ATR)
- INKT 1.44
- CLDI 0.24
- MACD
- INKT -0.07
- CLDI 0.01
- Stochastic Oscillator
- INKT 42.97
- CLDI 40.10
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.